13F

Stock

Neurocrine Biosciences Inc

NBIX · held by 13 managers

Reported value

$158.5M

Holders

13

+2 new · −0 exited

Holders’ est. mark

−$9.31M

Price effect on 7 books still in the name

Largest holder

$110.6M

NORGES BANK

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
NORGES BANK999.8K$110.6MHeld
BARCLAYS PLC200.2K$22.1M−$4.62MCut−$2.2M
PKO BP BANKOWY Universal Pension Society JSC138.8K$15.4M−$3.34MCut−$2.23M
DANSKE BANK A/S43.5K$4.82M−$1.06MCut−$768.5K
ONTARIO TEACHERS PENSION PLAN BOARD15.4K$1.7MNew
Swiss Life Asset Management Ltd15K$1.66M−$266.6KAdded$240.5K
OP Asset Management Ltd10.6K$1.18MHeld
Sanctuary Advisors, LLC3.96K$437.5KHeld
VIRTUS ADVISERS, LLC2.58K$285.8KHeld
Marex Group plc2.11K$233.5KNew
Leonteq Securities AG1.25K$138.5K−$21.7KAdded$23.5K
Prestige Wealth Management Group LLC44$4.87K−$1.14KCut−$1.14K
Aventura Private Wealth, LLC39$4.31K−$1.01KCut−$1.01K

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.